Zobrazeno 1 - 10
of 15
pro vyhledávání: '"OHKI TANIYAMA"'
Autor:
Ai Toyodome, Seiichi Mawatari, Hiromi Eguchi, Midori Takeda, Kotaro Kumagai, Ohki Taniyama, Sho Ijuin, Haruka Sakae, Kazuaki Tabu, Kohei Oda, Masanori Ikeda, Akio Ido
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Resistance-associated substitutions (RASs) of hepatitis C virus (HCV) affect the efficacy of direct-acting antivirals (DAAs). In this study, we aimed to clarify the susceptibility of the coexistence of nonstructural (NS) 5A Q24K/L28M/R30Q (o
Externí odkaz:
https://doaj.org/article/3fe6eb0227284a16be2ea8103fd1f582
Autor:
Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Background The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. Methods The study population included 1494 DAA-SVR p
Externí odkaz:
https://doaj.org/article/a9d631c3572b48d2b03ea489655c1018
Autor:
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Kotaro Kumagai, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Kunio Fujisaki, Dai Imanaka, Takeshi Kure, Ohki Taniyama, Ai Toyodome, Sho Ijuin, Haruka Sakae, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237475 (2020)
Background and aimsDirect-acting antivirals (DAAs) against hepatitis C virus (HCV) exert high anti-HCV activity and are expected to show anti-inflammatory effects associated with HCV elimination. Furthermore, hepatocellular carcinoma (HCC) is known t
Externí odkaz:
https://doaj.org/article/77e19cc7fd2f44569864b15ba39951ef
Autor:
Ai Toyodome, Seiichi Mawatari, Ohki Taniyama, Sho Ijuin, Haruka Sakae, Kazuaki Tabu, Kohei Oda, Kotaro Kumagai, Takashi Tasaki, Akio Ido
Publikováno v:
Clinical Journal of Gastroenterology. 16:416-421
Autor:
Seiichi Mawatari, Tsutomu Tamai, Kotaro Kumagai, Akiko Saisyoji, Kaori Muromachi, Ai Toyodome, Ohki Taniyama, Haruka Sakae, Sho Ijuin, Kazuaki Tabu, Kohei Oda, Yasunari Hiramine, Akihiro Moriuchi, Kazuhiro Sakurai, Shuji Kanmura, Akio Ido
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6139
The present study clarified the prognosis of intermediate-stage hepatocellular carcinoma (HCC) patients who received lenvatinib (LEN) followed by transcatheter arterial chemoembolization (TACE) on demand. We retrospectively evaluated 88 intermediate-
Autor:
Ai Toyodome, Tsutomu Tamai, Fumisato Sasaki, Masafumi Hashiguchi, Ohki Taniyama, Sho Ijuin, Haruka Sakae, Kazuaki Tabu, Kohei Oda, Kotaro Kumagai, Seiichi Mawatari, Akio Ido
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 12, p1749-1755, 7p
Autor:
Sho, Ijuin, Kohei, Oda, Seiichi, Mawatari, Ohki, Taniyama, Ai, Toyodome, Haruka, Sakae, Kazuaki, Tabu, Kotaro, Kumagai, Shuji, Kanmura, Tsutomu, Tamai, Akihiro, Moriuchi, Hirofumi, Uto, Akio, Ido
Publikováno v:
Molecular and Clinical Oncology
The prevalence of non-alcoholic fatty liver disease (NAFLD) is continuously increasing, with the proportion of patients with liver carcinogenesis due to non-alcoholic steatohepatitis (NASH) rising accordingly. Although it is important to identify ind
Autor:
Sho Ijuin, Kotaro Kumagai, Ai Toyodome, Shuji Kanmura, Kazuaki Tabu, Akio Ido, Kohei Oda, Ohki Taniyama, Seiichi Mawatari, Haruka Sakae
Publikováno v:
Molecular and Clinical Oncology
Highly sensitive Lens culinaris agglutinin-reactive fraction of α-fetoprotein (hs-AFP-L3) is a specific marker for hepatocellular carcinoma (HCC) and has been reliable in cases with a low serum α-fetoprotein (AFP) level. However, the biomarkers tha
Autor:
Kohei Oda, Dai Imanaka, Shuji Kanmura, Tsutomu Tamai, Kotaro Kumagai, Akio Ido, Yukiko Inada, Ohki Taniyama, Kazuhiro Sakurai, Takeshi Hori, Hirofumi Uto, Akihiro Moriuchi, Seiichi Mawatari, Takeshi Kure, Ai Toyodome, Akiko Saisyoji, Haruka Sakae, Kunio Fujisaki, Masafumi Hashiguchi, Yasunari Hiramine, Sho Ijuin, Kazuaki Tabu
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237475 (2020)
PLoS ONE
PLoS ONE
Background and aimsDirect-acting antivirals (DAAs) against hepatitis C virus (HCV) exert high anti-HCV activity and are expected to show anti-inflammatory effects associated with HCV elimination. Furthermore, hepatocellular carcinoma (HCC) is known t
Autor:
Kotaro Kumagai, Shuzo Tashima, Akio Ido, Kazuaki Tabu, Sho Ijuin, Tsutomu Tamai, Ai Kasai, Seiichi Mawatari, Kohei Oda, Akihiro Moriuchi, Ohki Taniyama
Publikováno v:
Hepatology Research. 49:239-243
A 68-year-old Japanese man with decompensated cirrhosis due to hepatitis C virus (HCV) genotype 1b infection was treated with sofosbuvir (SOF; 400 mg/day), ledipasvir (LDV; 90 mg/day), and ribavirin (RBV; 400 mg/day). Before treatment, his Child-Pugh